NCT06058845View on ClinicalTrials.gov

Efficacy of Tamarindus Indica Fruit Juice in Optimizing Cardiometabolic Health of Patients Living With HIV

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

January 25, 2024

Study Completion Date

January 30, 2024

Conditions
Cardiometabolic SyndromeDyslipidemiasHypertension
Interventions
DIETARY_SUPPLEMENT

Tamarindus indica fruit juice_A

The participants will be exposed to 10% Tamarind pulp juice

DIETARY_SUPPLEMENT

Tamarindus indica fruit juice_B

The participants will be exposed to 30% Tamarind pulp juice

Trial Locations (1)

256

Kajjansi HCIV, Wakiso

All Listed Sponsors
collaborator

Mildmay Uganda Limited

OTHER

lead

KU Leuven

OTHER

NCT06058845 - Efficacy of Tamarindus Indica Fruit Juice in Optimizing Cardiometabolic Health of Patients Living With HIV | Biotech Hunter | Biotech Hunter